125 related articles for article (PubMed ID: 37779450)
1. Does hydration status influence kidney volume in autosomal dominant polycystic kidney disease?
Naver SV; Jensen AM; Egfjord M; Ørskov B; Østergaard MGØ; Blankholm AD; Fallentin E; Pedersen M; Jensen JD
Clin Nephrol; 2023 Nov; 100(5):195-201. PubMed ID: 37779450
[TBL] [Abstract][Full Text] [Related]
2. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
3. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
[TBL] [Abstract][Full Text] [Related]
4. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
5. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
Nakajima A; Lu Y; Kawano H; Horie S; Muto S
Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
[TBL] [Abstract][Full Text] [Related]
6. Kidney volume and function in autosomal dominant polycystic kidney disease.
Higashihara E; Nutahara K; Okegawa T; Shishido T; Tanbo M; Kobayasi K; Nitadori T
Clin Exp Nephrol; 2014 Feb; 18(1):157-65. PubMed ID: 23864346
[TBL] [Abstract][Full Text] [Related]
7. Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
Higashihara E; Nutahara K; Tanbo M; Hara H; Miyazaki I; Kobayashi K; Nitatori T
Nephrol Dial Transplant; 2014 Sep; 29(9):1710-9. PubMed ID: 24739484
[TBL] [Abstract][Full Text] [Related]
8. Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease.
Suwabe T; Ubara Y; Oba Y; Mizuno H; Ikuma D; Yamanouchi M; Sekine A; Tanaka K; Hasegawa E; Hoshino J; Sawa N
J Nephrol; 2023 May; 36(4):999-1010. PubMed ID: 36753000
[TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vilayur E; Rangan GK
BMJ Open; 2018 Jan; 8(1):e018794. PubMed ID: 29358433
[TBL] [Abstract][Full Text] [Related]
10. Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Gansevoort RT; Hariri A; Minini P; Ahn C; Chapman AB; Horie S; Knebelmann B; Mrug M; Ong ACM; Pei YPC; Torres VE; Modur V; Antonshchuk I; Perrone RD
Am J Kidney Dis; 2023 May; 81(5):517-527.e1. PubMed ID: 36535535
[TBL] [Abstract][Full Text] [Related]
11. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
[TBL] [Abstract][Full Text] [Related]
12. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
Chebib FT; Torres VE
Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease.
Chen D; Ma Y; Wang X; Yu S; Li L; Dai B; Mao Z; Sun L; Xu C; Rong S; Tang M; Zhao H; Liu H; Serra AL; Graf N; Liu S; Wüthrich RP; Mei C
PLoS One; 2014; 9(3):e92232. PubMed ID: 24651850
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
[TBL] [Abstract][Full Text] [Related]
16. Effect of Kidney transplantation on cyst growth in autosomal dominant polycystic kidney disease.
Gaytan-Arocha JE; Pérez-Segovia A; Reul-Linares E; Hernández-Paredes EN; Chapa-Ibargüengoitia M; Correa-Rotter R; Morales-Buenrostro LE; Ramirez-Sandoval JC
Clin Nephrol; 2023 May; 99(5):228-236. PubMed ID: 36881881
[TBL] [Abstract][Full Text] [Related]
17. Utility of ultrasonography for predicting indications for tolvaptan in patients with autosomal dominant polycystic kidney disease.
Iijima H; Tada T; Hashimoto M; Nishimura T; Kiriki M; Higashiura A; Iwasaki A; Honda M; Nagasawa Y; Yamakado K
J Med Ultrason (2001); 2023 Jan; 50(1):81-87. PubMed ID: 36333536
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients.
Chen H; Watnick T; Hong SN; Daly B; Li Y; Seliger SL
BMC Nephrol; 2019 Oct; 20(1):386. PubMed ID: 31653199
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
[TBL] [Abstract][Full Text] [Related]
20. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
Kim K; Trott JF; Gao G; Chapman A; Weiss RH
BMC Nephrol; 2019 Feb; 20(1):66. PubMed ID: 30803434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
